STARSCAPE: A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2, PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

This study will evaluate the efficacy, safety, and pharmacokinetics of PRM-151 compared with placebo in patients with IPF. The study was terminated by Sponsor as the futility analysis outcome indicated that the study was unlikely to meet the predefined primary objective of the study. No new safety concerns were identified